Expression of the extracellular domain of the human immunodeficiency virus type 1 envelope protein and its fusion with beta-galactosidase in Saccharomyces cerevisiae
- PMID: 9665973
- PMCID: PMC95624
- DOI: 10.1128/CDLI.5.4.592-594.1998
Expression of the extracellular domain of the human immunodeficiency virus type 1 envelope protein and its fusion with beta-galactosidase in Saccharomyces cerevisiae
Abstract
Two envelope glycoprotein gene fragments were cloned from the proviral genome of the HXB2 isolate of human immunodeficiency virus (HIV). For the production of the two domains of the envelope gene product these cloned gene fragments were inserted into an Escherichia coli-yeast inducible shuttle vector fused to the galactokinase (GAL1) promoter. Cell extracts from strains of Saccharomyces cerevisiae harboring these two vectors (pYENV1 and pYENV2) were found to contain a specific protein with a size of 50 kDa when induced by galactose, while the protein could not be detected in extracts from control cells containing only the E. coli-yeast vector in the presence of galactose. Furthermore, another expression plasmid coding for fusion proteins from the majority of the external envelope glycoprotein (gp120) moiety and a large part of the beta-galactosidase was constructed. Antibodies from HIV type 1-positive sera could react with recombinant fusion polypeptides. Transformants could produce this fusion protein to a level of about 1.6% of the total protein content, as deduced from beta-galactosidase activity.
Figures


Similar articles
-
Presentation of native epitopes in the V1/V2 and V3 regions of human immunodeficiency virus type 1 gp120 by fusion glycoproteins containing isolated gp120 domains.J Virol. 1994 Jan;68(1):400-10. doi: 10.1128/JVI.68.1.400-410.1994. J Virol. 1994. PMID: 7504740 Free PMC article.
-
Antibodies of symptomatic human immunodeficiency virus type 1-infected individuals are directed to the V3 domain of noninfectious and not of infectious virions present in autologous serum.J Virol. 1994 Jun;68(6):3908-16. doi: 10.1128/JVI.68.6.3908-3916.1994. J Virol. 1994. PMID: 8189527 Free PMC article.
-
A peptide library expressed in yeast reveals new major epitopes from human immunodeficiency virus type 1.FEMS Microbiol Immunol. 1991 Apr;3(2):99-107. doi: 10.1111/j.1574-6968.1991.tb04203.x. FEMS Microbiol Immunol. 1991. PMID: 1713777
-
Molecular approaches to AIDS vaccine development using baculovirus expression vectors.Methods Mol Biol. 1995;39:295-315. doi: 10.1385/0-89603-272-8:295. Methods Mol Biol. 1995. PMID: 7542523 Review. No abstract available.
-
Biodiversity and bioseparation of HIV-1 envelope glycoproteins.Crit Rev Oncog. 1999;10(1-2):1-16. Crit Rev Oncog. 1999. PMID: 10327209 Review.
References
-
- Barr P J, Steimer K S, Sabin E A, Parkes D, George-Nascimento C, Stephans J C, Wers M A, Gyenes A, Van Nest G A, Miller E T, Higgins K W, Luciw P A. Antigenicity and immunogenicity of domains of the human immunodeficiency virus (HIV) envelope polypeptide expressed in the yeast Saccharomyces cerevisiae. Vaccine. 1987;5:90–101. - PubMed
-
- Bolognesi D. Progress in vaccine developement against SIV and HIV. J Acquired Immune Defic Syndr. 1990;3:390–394. - PubMed
-
- Chirmule N, Kalyanaraman V, Oyaizu N, Pahwa S. Inhibitory influences of envelope glycoproteins of HIV-1 on normal immune responses. J Acquired Immune Defic Syndr. 1988;1:425–430. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials